尿検査市場の規模、シェア、成長分析、検査別、用途別、エンドユーザー別、地域別 - 産業予測、2025～2032年

尿検査の世界市場規模は、2023年に24億米ドルと評価され、2024年の25億1,000万米ドルから2032年には35億4,000万米ドルに拡大し、予測期間（2025-2032年）のCAGRは4.4％で成長する見通しです。

尿検査市場は、医療機器、特に尿分析装置と関連製品の進歩に牽引され、急成長が見込まれています。ヘルスケアインフラの改善とアンメットヘルスニーズの高まり、特に糖尿病などの慢性疾患の有病率の増加が、尿検査ソリューションの需要を促進しています。温州の国立衛生研究所（NIH）が実施した大規模な尿スクリーニングなど、政府が開始したスクリーニング・プログラムは病気の早期発見を強化し、市場の拡大をさらに刺激すると予想されます。さらに、男女を問わず蔓延している尿路感染症の発生率の上昇が、糖尿病やさまざまな腎臓の問題の診断に重要な役割を果たす尿検査の必要性を煽っています。全体として、尿検査市場は新興市場で大きな成長を遂げようとしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

尿検査市場規模：検査別

• 市場概要
• 妊娠と不妊検査
• 尿生化学的検査
• 尿沈渣検査

尿検査市場規模：用途別

• 市場概要
• 疾患スクリーニング
• 妊娠と生殖能力

尿検査市場規模：エンドユーザー別

• 市場概要
• 病院・クリニック
• 診断検査室
• 在宅ケア環境
• 調査室・研究所

尿検査市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Cardinal Health（US）
• General Electric Company（US）
• Metropolis India（India）
• 77 Elektronika Kft（Hungary）
• Roche Diagnostics（Switzerland）
• Thermo Fisher Scientific（US）
• Sysmex Corporation（Japan）
• Abbott（US）
• Trinity Biotech（Ireland）
• ARKRAY Inc.（Japan）
• Dr Lal PathLabs（India）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Siemens（Germany）
• Sysmex Corporation（Japan）
• BioMaxima SA（Poland）

結論と推奨事項

Global Urinalysis Test Market size was valued at USD 2.4 billion in 2023 and is poised to grow from USD 2.51 billion in 2024 to USD 3.54 billion by 2032, growing at a CAGR of 4.4% during the forecast period (2025-2032).

The urinalysis test market is poised for rapid growth, driven by advancements in medical equipment, particularly in urine analyzers and related products. Improved healthcare infrastructure and rising unmet health needs, especially the increasing prevalence of chronic diseases like diabetes, are propelling demand for urine testing solutions. Screening programs initiated by governments, such as the significant urine screenings conducted by the National Institute of Health (NIH) in Wenzhou, are enhancing early disease detection and are expected to further stimulate market expansion. Additionally, the rising incidence of urinary tract infections, prevalent in both genders, is fueling the necessity for urinalysis testing, which plays a critical role in diagnosing diabetes and various renal issues. Overall, the market for urine tests is set for significant growth in emerging markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinalysis Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Urinalysis Test Market Segmental Analysis

Global Urinalysis Test Market is segmented by Application, End User, Test and region. Based on Test, the market is segmented into Pregnancy & Fertility Tests, Biochemical Urinalysis and Sediment Urinalysis. Based on Application, the market is segmented into Disease Screening and Pregnancy and Fertility. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Home Care Setting and Research Laboratories & Institute. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Urinalysis Test Market

The global urinalysis test market is primarily driven by the increasing prevalence of diabetes and urinary tract infections (UTIs), particularly in developing countries. The surge in UTI cases poses significant health risks, as untreated infections can lead to complications during childbirth and may spread to the kidneys, highlighting the critical need for timely diagnosis and treatment. As awareness of these conditions grows, the demand for urinalysis tests is expected to rise, further propelling market growth. Additionally, improved access to healthcare services and advancements in diagnostic technologies are enhancing the overall landscape of the urinalysis test market.

Restraints in the Global Urinalysis Test Market

One of the key restraints in the global urinalysis test market is the limited accessibility to advanced urine analyzers, particularly in developing countries where cost is a major concern. In these regions, healthcare providers often opt for more affordable devices that offer similar functionalities, leading to increased demand for budget-friendly alternatives. Furthermore, the lack of robust regulatory frameworks can result in an influx of substandard and refurbished products in the market, undermining the quality of diagnostic services and potentially risking patient safety. This scenario creates significant challenges for manufacturers aiming to introduce high-quality, innovative solutions in these emerging markets.

Market Trends of the Global Urinalysis Test Market

The Global Urinalysis Test market is experiencing a notable trend driven by advancements in diagnostic technology, particularly through automated urine analyzers and smartphone-integrated testing devices. These innovations enhance the precision and accessibility of urinalysis, catering to both healthcare professionals and patients. As chronic illnesses such as diabetes and kidney disease rise, the demand for efficient urinalysis tests is surging, reinforcing their integral role in early health problem detection and management. This expanding requirement for streamlined testing methods emphasizes urinalysis as a cornerstone of modern healthcare, propelling market growth and innovation in diagnostic approaches for better patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Urinalysis Test Market Size by Test & CAGR (2025-2032)

• Market Overview
• Pregnancy & Fertility Tests
• Biochemical Urinalysis
• Sediment Urinalysis

Global Urinalysis Test Market Size by Application & CAGR (2025-2032)

• Market Overview
• Disease Screening
• Pregnancy and Fertility

Global Urinalysis Test Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care Setting
• Research Laboratories & Institute

Global Urinalysis Test Market Size & CAGR (2025-2032)

• North America (Application, End User, Test)
  • US
  • Canada
• Europe (Application, End User, Test)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, End User, Test)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, End User, Test)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, End User, Test)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Cardinal Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metropolis India (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 77 Elektronika Kft (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr Lal PathLabs (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMaxima SA (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations